Hormone Therapy Linked to Autoimmune Disease Risk in Postmenopausal Women
A recent study presented at the annual meeting of the Menopause Society found that hormone therapy (HT) use is associated with an increased incidence and risk for developing autoimmune disease in postmenopausal women.
- Significant increases in risk were linked to menopausal hormone therapy for all autoimmune diseases except Graves disease and hepatitis.
- The study included 889,413 postmenopausal women in both HT and non-HT cohorts after propensity score-matching.
- HT users had a higher incidence of autoimmune disease at five years (6.7% vs 5.3%), at 10 years (8.6% vs 6.7%), and across the postmenopausal period (9.0% vs 7.1%) compared to non-HT users.
According to the study, hormone therapy use is associated with an increased incidence and risk for developing autoimmune disease in postmenopausal women.
Author's summary: Hormone therapy is linked to increased autoimmune disease risk in postmenopausal women.
More News
- Islanders vs. Lightning (Dec 6, 2025) Pregame
- Kelly Vedovelli révèle sa vie amoureuse
- Spurs' Luke Kornet out Friday
- Hamilton urges Ferrari to make 'personnel changes' ahead of F1 2026
- F1 2026 : Lancements, livrées et premiers indices d'une révolution en piste
- Kelly Massol : « J’ai réalisé 40% de mon ambition »
- When does 2026 F1 season start?
- Jay Kelly cast guide: All on which characters George Clooney, Adam Sandler and Laura Dern play in the film
- Lando Norris wins his first F1 title despite Max Verstappen victory: Live updates and reaction
- Pelicans' Questionable Offseason Trade Looks Better After Saddiq Bey's Rise